The post LDO Price Prediction: Dead Cat Bounce to $0.35 Before $0.25 Crater appeared on BitcoinEthereumNews.com. Terrill Dicki May 31, 2026 08:37 LDO’s oversoldThe post LDO Price Prediction: Dead Cat Bounce to $0.35 Before $0.25 Crater appeared on BitcoinEthereumNews.com. Terrill Dicki May 31, 2026 08:37 LDO’s oversold

LDO Price Prediction: Dead Cat Bounce to $0.35 Before $0.25 Crater

For feedback or concerns regarding this content, please contact us at [email protected]


Terrill Dicki
May 31, 2026 08:37

LDO’s oversold bounce hits a brick wall at $0.33 resistance with smart money positioning bullish while retail sells aggressively. Target $0.35 relief rally before inevitable breakdown to $0.25.

The Immediate Setup

Lido DAO is bleeding out in slow motion at $0.32, trapped in a technical no-man’s land that screams distribution phase. The token managed a pathetic 0.87% bounce in the last 24 hours, but volume tells the real story – only $1.5M in spot trading suggests institutional money has completely abandoned ship. Technical indicators paint a picture of momentum completely stalled, with the RSI hovering in dangerous neutral territory at 37.42 where false breakouts love to hunt stop losses.

The momentum oscillators confirm this stagnation, with the MACD histogram essentially flatlined at zero while remaining deep in negative territory. This isn’t capitulation yet, but it’s the setup that precedes it. Blockchain.news data shows LDO has been systematically rejected at every meaningful resistance level, and the current price action suggests another leg down is brewing.

Key Levels Exposed

The moving average stack tells a brutal story of systematic rejection. LDO trades 28% below its 200-day SMA at $0.45, while even the shorter-term 20-day SMA at $0.35 acts as concrete resistance. The token is hugging the lower Bollinger Band at $0.31 with severe oversold conditions that could fuel a sharp relief bounce, though the %B position of 0.18 indicates how deeply oversold conditions have become.

Strong resistance sits at $0.33, which aligns perfectly with the 7-day SMA and represents the immediate battleground. Below current levels, strong support theoretically exists at $0.31, but given the lack of institutional buying pressure, this level will likely crumble like wet paper when tested. Volatility compression is evident with the Average True Range sitting at just $0.02, often a precursor to explosive moves in either direction.

Sentiment vs Reality

The disconnect between institutional and retail positioning reveals the market’s true hand. Top traders maintain a bullish 56.3% long bias through futures positioning, while the taker buy/sell ratio shows aggressive selling pressure with nearly twice as much sell volume as buy volume. This divergence typically signals that smart money is accumulating while retail capitulates.

The neutral funding rate of 0.0088% indicates no immediate short squeeze pressure building, while the 3.58% decline in open interest shows traders are closing positions rather than adding leverage. Blockchain.news analysis confirms that this type of positioning often precedes violent bounces as shorts get overextended and smart money steps in to capitalize on retail panic.

Actionable Trade Strategy

The setup screams counter-trend bounce trade with tight risk management. Entry zone sits between $0.315-$0.32 with a hard stop loss at $0.305 – any break below this level invalidates the bounce thesis and opens the door to $0.25. Target the initial resistance cluster at $0.33-$0.335 for quick 3-5% gains, with secondary targets at the 20-day SMA around $0.35.

The risk/reward favors aggressive shorts on any failed bounce above $0.33, particularly if volume remains anemic. Given the technical damage and institutional distribution patterns, LDO likely tests $0.25 within the next 2-3 weeks regardless of any short-term relief rallies. Position sizing should reflect the high probability of continued downside – this is a trade, not an investment.

Blockchain.news Crypto Market


Hourly candlesticks (about 96 bars), same endpoint as our cryptocurrency price pages. Numbers below refresh from 1-minute klines.

Full LDO price, calculator & analysis

Image source: Shutterstock

Source: https://blockchain.news/news/20260531-price-prediction-ldo-dead-cat-bounce-to-035-before

Market Opportunity
Lido DAO Logo
Lido DAO Price(LDO)
$0,3227
$0,3227$0,3227
+%0,18
USD
Lido DAO (LDO) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage